| 2006 (1st) |
Calcutta |
Dr. YK Chawla |
Hepatic Fibrosis-Basic Science to Therapy |
— |
| 2007 (2nd) |
Pattaya |
Dr. C Pramoolsinsap |
The Innovation in Chronic Hepatitis B Treatment |
1st APASL HBV Conference |
| 2008 (3rd) |
Cairo |
Dr. G Shiha
Dr. A Ibrahim |
Liver Fibrosis |
1st APASL Liver Fibrosis Conference |
| 2008 (4th) |
Bali |
Dr. L Lesmana |
Hepatocellular Carcinoma |
1st APASL HCC Conference |
| 2009 (5th) |
Istanbul |
Dr. AK Dökmeci |
Non Responders |
— |
| 2009 (6th) |
Karachi |
Dr. S Hamid
Dr. W Jafri |
Acute Liver Failure : Asian-Pacfic Perspectives |
1st APASL ACLF Conference |
| 2010 (7th) |
Chiba |
Dr. O Yokosuka |
HCV |
1st APASL HCV Conference |
| 2011 (8th) |
Beijing |
Dr. FS Wang |
Hepatitis B Virus |
2nd APASL HBV Conference |
| 2011 (9th) |
Jeju |
Dr. BC Yoo |
Hepatocellular Carcinoma |
2nd APASL HCC Conference |
| 2012 (10th) |
Ulaan baatar |
Dr. A Jazag |
HBV & HCV Dual Infection |
2nd APASL HCV Conference |
| 2012 (11th) |
Dhaka |
Dr. S Rahman |
HBV |
3rd APASL HBV Conference |
| 2013 (12th) |
Cebu |
Dr. D Payawal |
HCC |
3rd APASL HCC Conference |
| 2013 (13th) |
Jakarta |
Dr. R Gani |
NASH |
1st APASL NASH Conference |
| 2014 (14th) |
Cairo |
Dr. G Shiha |
Liver Fibrosis |
2nd APASL Liver Fibrosis Conference |
| 2014 (15th) |
Karachi |
Dr. Z Abbas |
HCV |
3rd APASL HCV Conference |
| 2014 (16th) |
Guangzhou |
Dr. JL Hou |
HBV |
4th APASL HBV Conference |
| 2015 (17th) |
Yerevan |
Dr. H Ghazinyan |
HBV |
5th APASL HBV Conference |
| 2015 (18th) |
New Delhi |
Dr. BC Sharma |
HCV |
4th APASL HCV Conference |
| 2016 (19th) |
Busan |
Dr. KH Han |
Liver Cirrhosis |
1st APASL Liver Cirrhosis Conference |
| 2016 (20th) |
Kaohsiung |
Dr. WL Chuang |
HCV |
5th APASL HCV Conference |
| 2016 (21st) |
Beijing |
Dr. Lai Wei |
HBV |
6th APASL HBV Conference |
| 2017 (22nd) |
Nagasaki |
Dr. Hiroshi Yatsuhashi |
HCC |
4th APASL HCC Conference |
| 2017 (23rd) |
Ulaanbaatar |
Dr. Oidov Baatarkhuu |
HCV and coinfection |
6th APASL HCV Conference |
| 2017 (24th) |
Cairo |
Dr. Gamal Shiha |
HCV |
7th APASL HCV Conference |
| 2018 (25th) |
Yokohama |
Dr. Shuichiro Shiina |
HCC |
5th APASL HCC Conference |
| 2018 (26th) |
Taipei |
Dr. Rong-Nan Chien |
HBV in Asia-Pacific |
7th APASL HBV Conference |
| 2018 (27th) |
Kuala Lumpur |
Dr. Rosmawati Mohamed |
HCV |
8th APASL HCV Conference |
| 2018 (28th) |
Istanbul |
Dr. Necati Ormeci |
Non-Responder |
— |
| 2018 (29th) |
Beijing |
Dr. Gui-Qiang Wang |
Autoimmune |
— |
| 2019 (30th) |
Tokyo |
Dr. Atsushi Tanaka |
Liver Immunology and Genetics |
— |
| 2019 (31st) |
Baku |
Dr. Gulnara Aghayeva |
Hepatitis Delta |
— |
| 2020 (32nd) |
Guangzhou |
Dr. Xiaolong Qi |
Portal Hypertension |
— |
| 2021 (33rd) |
Osaka |
Dr. Norifumi Kawada |
Molecular and Cellular Biology |
— |
| 2021 (34th) |
Tokyo |
Dr. Mitsuhiko Moriyama |
Oncology |
1st APASL 2021 Oncology
6th APASL HCC Conference |
| 2022 (35th) |
Beijing |
Dr. Hong You |
Liver Fibrosis |
— |
| 2022 (36th) |
Taipei |
Dr. Chun-Jen Liu |
Paradigm Shift of HCC Management: Across Viral to Steatogenic Carcinogenesis |
7th APASL HCC Conference |
| 2022 (37th) |
Cairo |
Dr. Gamal Shiha |
Liver Fibrosis: Liver Fibrosis in the era of MAFLD |
— |
| 2022 (38th) |
Takamatsu |
Dr. Tsutomu Masaki |
HCC：Clinical and basic research |
2nd APASL 2022 Oncology
8th APASL HCC Conference |
| 2022 (39th) |
Wuhan |
Dr. Qin Ning |
Critical Care in Hepatology ACLF |
— |
| 2022 (40th) |
Istanbul |
Dr. Ibrahim Halil Bahcecioglu |
Hepatotoxicity |
— |
| 2022 (41st) |
Yerevan |
Dr. Hasmik Ghazinian |
NAFLD/NASH: Non-Infection Epidemic in XXI |
— |
| 2022 (42nd) |
Guangzhou |
Dr. Jinjun Chen |
Image-guided Interventions in Liver Diseases |
— |
| 2023 (43rd) |
Manila |
Dr. Ian Homer Y. Cua |
Liver Cirrhosis and Its Complication |
— |
| 2023 (44th) |
Busan |
Dr. Si Hyun Bae |
Viral Hepatitis |
— |
| 2023 (45th) |
Sendai |
Dr. Yoshiyuki Ueno |
Oncology |
3rd APASL 2023 Oncology
9th APASL HCC Conference |
| 2024 (46th) |
Kaohsiung |
Dr. Ming Lung Yu |
Metabolic Disorders |
— |
| 2024 (47th) |
Chiba |
Dr. Naoya Kato |
Genomics Meets Immunology |
4th APASL 2024 Oncology
10th APASL HCC Conference |
| 2024 (48th) |
Bali |
Dr. Cosmas Rinaldi A. Lesmana |
New Concept of Portal Hypertension and Hepatobiliary Malignancy related |
— |
| 2024 (49th) |
Almaty |
Dr. Alexander Nersesov |
Liver Cirrhosis: Common and Rare Complications |
|
| 2025 (50th) |
Mumbai |
Dr. Akash Shukla |
Improving Non-transplant Outcomes in Patients with Advanced Liver Disease |
|
| 2025 (51st) |
Istanbul |
Dr. Vedat Goral |
Liver Cirrhosis: Current and New Therapies |
|
| 2025 (52nd) |
Tashkent |
Dr. Musabaev Erkin |
Viral Hepatitis Elimination by 2030: Progress and Challenges |
|
| 2025 (53rd) |
Taipei |
Dr. Yi-Hsiang Huang |
Oncology-Multifaceted Approach and Treatment for Liver Cancer |
5th APASL 2025 Oncology
11th APASL HCC Conference |
| 2025 (54th) |
Moscow |
Dr. Andrey Kostin |
Alcoholic Liver Disease |
3rd APASL NASH Conference |
| 2025 (55th) |
Tokyo |
Dr. Kenichi Ikejima |
New Horizons for Steatotic Liver Disease: Cutting Edge Research and Emerging Therapeutics |
4th APASL NASH Conference |
| 2025 (56th) |
Qingdao |
Dr. Jinzhen Cai |
Full Process Management of Liver Transplant Patients |
|
| 2025 (57th) |
Karachi |
Dr. Amna Subhaan Butt |
MAFLD and Metabolic Complications: Applying Multidisciplinary Solutions |
5th APASL NASH Conference |
| 2025 (58th) |
Yangon |
Dr. Kyaw Soe Tun |
Current Management of HCC with Local Relevance |
12th APASL HCC Conference |
| 2026 (59th) |
New Delhi |
Dr. Seema Alam |
Wilson Disease : New Concepts in Diagnosis and Management |
|
| 2026 (60th) |
Tokyo |
Dr. Shuntaro Obi |
Oncology: Treatment Dynamics of Liver Tumors |
6th APASL 2026 Oncology |
| 2026 (61st) |
Singapore |
Dr. Mark Muthiah |
Aetiology Specific Considerations in Optimizing Care of the Cirrhotic Patient |
|
| 2026 (62nd) |
Kumamoto |
Dr. Yasuhito Tanaka |
Liver Cancer Control – Ending Hepatitis, Halting MASLD/MAFLD – |
|
| 2026 (63rd) |
Almaty |
Dr. Alexander V. Nersesov |
Liver Diseases and Pregnancy |
|
| 2027 (64th) |
Bishkek |
TBA |
MASLD |
|
| 2027 (65th) |
Kaohsiung |
Dr. Chia-Yen Dai |
MASLD |
|
| 2026 (64th) |
Dhaka |
Dr. Shahinul Alam |
MAFLD: Evidence-based, Multidisciplinary Approach in the Era of Targeted Therapy |
|
| 2027 (65th) |
Bishkek |
Dr. Nurgul Toktogulova |
MASLD/MAFLD |
|
| 2027 (66th) |
Istanbul |
Dr. Mehmet Asil |
Unmet Needs in Liver Diseases |
|
| 2027 (67th) |
Kaohsiung |
Dr. Chia-Yen Dai |
MASLD/MAFLD |
|
| 2027 (68th) |
Danang |
Dr. Le Trung Hai |
From Chronic Liver Disease to HCC |
|
| 2027 (69th) |
Chongqing |
Dr. Jinjun Chen |
Clinical Application of Liver Imaging in A.I. Era |
|
| 2027 (70th) |
Karachi |
Dr. Amna Subhan Butt |
Viral Hepatitis–MAFLD Overlap: Defining Pathways for Integrated Management |
|